Abhishek Iyer

Abhishek Iyer

Auto-generated profile, based on publicly available information

Abhishek Iyer

School of Pharmacy, Joseph Banks Laboratories, University of Lincoln, Green Lane, Lincoln LN6 7DL, UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2016 in Chemical Communications
Verified
Journal Article
Open access
PDF file
APAnish Parmar
Anish Parmar
AIAbhishek Iyer
Abhishek Iyer
CVCharlotte S. Vincent
Charlotte S. Vincent
DLDorien Van Lysebetten
Dorien Van Lysebetten
SPStephen H. Prior
Stephen H. Prior
Ishwar SinghIshwar Singh
Ishwar Singh
Efficient total syntheses of teixobactin analogues and their structure activity relationships are reported. The advantages of the synthetic approach are a high yield (22% for analogue1), key step of the macrocyclisation achieved in 60 minutes.

5 October 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
APAnish Parmar
Anish Parmar
AIAbhishek Iyer
Abhishek Iyer
SPStephen H. Prior
Stephen H. Prior
DLDaniel G. Lloyd
Daniel G. Lloyd
EGEunice Tze Leng Goh
Eunice Tze Leng Goh
Ishwar SinghIshwar Singh
Ishwar Singh
Leu 10 -teixobactin and Ile 10 -teixobactin have shown comparable activity to natural teixobactin.

13 January 2017 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
APAnish Parmar
Anish Parmar
SPStephen H. Prior
Stephen H. Prior
AIAbhishek Iyer
Abhishek Iyer
CVCharlotte S. Vincent
Charlotte S. Vincent
DLDorien Van Lysebetten
Dorien Van Lysebetten
Ishwar SinghIshwar Singh
Ishwar Singh
In this work, we have for the first time defined the molecular structure of seven teixobactin analogues through the variation of the d/l configuration of its key residues.

19 June 2017 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
APAnish Parmar
Anish Parmar
AIAbhishek Iyer
Abhishek Iyer
DLDaniel G. Lloyd
Daniel G. Lloyd
CVCharlotte S. Vincent
Charlotte S. Vincent
SPStephen H. Prior
Stephen H. Prior
Ishwar SinghIshwar Singh
Ishwar Singh
The recently discovered cyclic depsipeptide, teixobactin, is a highly potent antibiotic against multi-drug resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and Mycobaterium tuberculosis. It comprises of 4 D amino acids and a rare L-allo-enduracididine amino acid. The synthesis of a properly protected L-allo-enduracididine amino acid and its incorporation into teixobactin is time consuming, synthetically challenging and low yielding and is therefore a major bottleneck in the development of potent analogues of teixobactin. In this article, we have synthesised 8 analogues of teixobactin using commercially available building blocks by replacing the L-allo-enduracididine amino acid with its isosteres. Furthermore, we have tested all the compounds against a panel of Gram positive bacteria including MRSA and explained the observed trend in biological activity. Although all the analogues were active, three analogues from this work, showed very promising activity against MRSA (MIC 1 μg mL−1). We can conclude that amino acids which are the closest isosteres of L-allo-enduracididine are the key to synthesising simplified potent analogues of teixobactin using rapid syntheses and improved yields.

17 February 2015 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
AIAbhishek Iyer
Abhishek Iyer
DLDorien Van Lysebetten
Dorien Van Lysebetten
YGYara Ruiz García
Yara Ruiz García
BLBenoit Louage
Benoit Louage
BGBruno G. De Geest
Bruno G. De Geest
AMAnnemieke Madder
Annemieke Madder
Facile synthesis of DNA binding stapled peptides which show enhanced cellular uptake is described considering the GCN4 transcription factor as a model protein.

11 October 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RMRuba Malkawi
Ruba Malkawi
AIAbhishek Iyer
Abhishek Iyer
APAnish Parmar
Anish Parmar
DLDaniel G. Lloyd
Daniel G. Lloyd
EGEunice Tze Leng Goh
Eunice Tze Leng Goh
Ishwar SinghIshwar Singh
Ishwar Singh
Teixobactin is a highly potent cyclic depsipeptide which kills a broad range of multi-drug resistant, Gram-positive bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA) without detectable resistance. In this work, we describe the design and rapid synthesis of novel teixobactin analogues containing two cysteine moieties, and the corresponding disulfide-bridged cyclic analogues. These analogues differ from previously reported analogues, such as an Arg10-teixobactin, in terms of their macrocyclic ring size, and feature a disulfide bridge instead of an ester linkage. The new teixobactin analogues were screened against Methicillin-resistant Staphylococcus aureus and Methicillin-sensitive Staphylococcus aureus. Interestingly, one teixobactin analogue containing all l-amino acid building blocks showed antibacterial activity against MRSA for the first time. Our data indicates that macrocyclisation of teixobactin analogues with disulfide bridging is important for improved antibacterial activity. In our work, we have demonstrated the unprecedented use of a disulfide bridge in constructing the macrocyclic ring of teixobactin analogues.